This inventor holds 38 USPTO granted patents and 1 EPO patent, primarily in Biologically Active Compounds. Top assignees: Colorado State University Research Foundation, Dana-Farber-Cancer Institute Inc., University of Notre Dame Du Lac. Active years: 1982-2025.
Location History:
- Ladue, St. Louis County, MO (US) (1983)
- Green Bay, WI (US) (1984)
- Washington, DC (US) (1982 - 1998)
- St. Louis, MO (US) (1992 - 1999)
- Davison, MI (US) (1984 - 2005)
- Fort Collins, CO (US) (1993 - 2020)
Company Filing History:
11 out of 488Â 
5 out of 1,264Â 
4 out of 385Â 
Years Active: 1982-2025
Areas of Expertise:
Title: The Innovative Contributions of Robert M. Williams in Cancer Treatment
Introduction
Robert M. Williams, based in Fort Collins, CO, is a prolific inventor with an impressive portfolio of 37 patents. His groundbreaking work primarily focuses on the development of analogs of largazole, a compound significant for its potential therapeutic applications in treating various diseases, including cancer and blood disorders.
Latest Patents
Among his latest patents are the methods for preparing largazole analogs and their uses. These patents detail the synthesis and application of these analogs in treating cancer, blood disorders, and pharmaceutical compositions that comprise these compounds. Specifically, one of his noteworthy patents describes methods for treating not only cancer and blood disorders but also autoimmune diseases and Alzheimer's Disease using these innovative largazole analogs. The depth of his work in this area highlights his commitment to advancing medical science through advanced therapeutic methods.
Career Highlights
Throughout his career, Robert has made significant strides in the field of pharmaceutical chemistry. His involvement with research institutions, particularly the Colorado State University Research Foundation, has been pivotal in propelling his innovative contributions. His extensive research and patent filings reflect a deep understanding of both the scientific and practical aspects of drug development.
Collaborations
Collaboration has been a key aspect of Robert M. Williams's journey as an inventor. He has worked closely with esteemed colleagues, including Albert A. Bowers and Tenaya L. Newkirk. Their collective expertise and shared vision have undoubtedly enriched Robert's research endeavors, fostering innovation within their respective fields.
Conclusion
Robert M. Williams stands out as a prominent figure in the realm of medicinal chemistry. His innovative patents and collaborative efforts pave the way for new treatments that hold promise for patients facing some of the most challenging health conditions. As he continues to develop his research and file new patents, the impact of his work will likely resonate within the scientific community and beyond.